Smithkline Beecham Corporation

Other

Conrad Gerald Chapman

David J Powell

Joanne Rachel Evans

Christopher Donald Southan

Kay Elizabeth Murphy

Israel Simon Gloger

Hugh Jonathan Herdon

Anthony M Brown

Trudi S Smith

William Cairns

Derk J Bergsma

Peter R Young

Catherine E Ellis

Jeffrey L Mooney

David Malcolm Duckworth

John Timothy Lonsdale

Helen Elizabeth Clinkenbeard

Allan R Shatzman

Nicola Anne Burgess

Helen Jane Meadows

Michael Joseph Browne

Megan E Depiera

ASP2 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing ASP2 polypeptides and polynucleotides in the design of protocols for the treatment of Alzheimer's Disease, cancer, and prohormone processing, among others, and diagnostic assays for such conditions.

ASP2

The SC6 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing SC6 polypeptides and polynucleotides in therapy, and diagnostic assays for such.

Neurotransmitter transporter SC6

h-TRAAK polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing h-TRAAK polypeptides and polynucleotides in diagnostic assays.

Polynucleotides encoding a human potassium channel

Fatty Acid Synthase polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilising Fatty Acid Synthase polypeptides and polynucleotides in therapy, and diagnostic assays for such.

Human FAS

h-TREK1 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing h-TREK1 polypeptides and polynucleotides in therapy, and diagnostic assays for such.

h-TREK1 polypeptides and h-TREK1 polynucleotides

METPRO02 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing METPRO02 polypeptides and polynucleotides in therapy, and diagnostic assays for such.

Compounds

ASP1 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing ASP1 polypeptides and polynucleotides in the design of protocols for the treatment of Alzheimers's Disease, cancer, and melanoma, among others, and diagnostic assays for such conditions.

ASP1

A soluble protein having IL4 and/or IL13 antagonist or partial antagonist activity comprises an IL4 mutant or variant fused to least one human immunoglobulin constant domain or fragment thereof.

Therapeutic uses of fusion proteins between mutant IL 4/IL13 antagonists

Growing community of inventors

Orpington, United Kingdom

Conrad Gerald Chapman